/Sponsor / Executive Profile

Mark C. McKenna

Executive

Aggregate Capital Deployment Matrix

Active/Searching: $125M (45.5%)

Professional Biography

Mr. McKenna served as Chairman and Chief Executive Officer of Prometheus Biosciences (Nasdaq: RXDX) from 2019-2023.

Total Capital Deployed

$275,000,000

Active / Searching Capital:
$125,000,000

Transaction Volume

3 Transactions

Time-to-Liquidity (Months)

-

Merger Completion Rate

33.3%

Professional Network Intelligence

Frequent Underwriters

Frequent Associates

Top Sectors

  • Biotechnology1 Deals

Syndicate Deal History

TickerCompanyStatusTrustPriceWarrantIPO DateTime LeftDeal ValueSectorBookrunner
HLXC
Helix Acquisition Corp. III
searching
125.0M
$10.00
-Dec 2025
20mo
-GeneralOppenheimer & Co., Inc.
BBOT
Helix Acquisition Corp. II
closed
150.0M
$10.00
-Jan 2024Done
310.0M
BiotechnologyLeerink Partners LLC
NAMS
NewAmsterdam Pharma Company N.V.
announced
-
$10.00
-Dec 2022-
391.0M
General